CLINICAL_TRIALS
research
· 2010-07-07
Clinical Trial Update: A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy [NA]
Summary
A randomized study compares lamivudine versus adefovir dipivoxil to prevent hepatitis B reactivation in HBsAg-positive patients undergoing cytotoxic chemotherap…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital Authority, Hong Kong | Conditions: Hepatitis B | NA | Status: UNKNOWN